Importantly, TGF-β also inhibits cytotoxic T cell and NK cells-mediated anti-tumor immune response (Lawrence and Natoli, 2011; Noy and Pollard, 2014; Ruffell and Coussens, 2015). Here, TGFB1 is linked to neoplasm.